MegaPro Biomedical Co

MegaPro Biomedical Co Dividend

Dividend of MegaPro Biomedical Co (6827.TWO) as of Oct 15, 2026.

Dividend

0.00TWD

Last updated:

How much dividend does MegaPro Biomedical Co 2026 pay?

According to the latest status from October 2026, MegaPro Biomedical Co paid a total of 0.00 TWD per share in dividends within the last 12 months. With the current MegaPro Biomedical Co price of 13.70 TWD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical MegaPro Biomedical Co Dividends

Historical MegaPro Biomedical Co Dividends
PaydateDividend

The MegaPro Biomedical Co Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2018
0.00 TWD
Jan 1, 2019
0.00 TWD
Jan 1, 2020
0.00 TWD
Jan 1, 2021
0.00 TWD
Jan 1, 2022
0.00 TWD
Jan 1, 2023
0.00 TWD
Jan 1, 2024
0.00 TWD
Jan 1, 2025
0.00 TWD
The MegaPro Biomedical Co Dividend history
YEARDividendYoY
0.00TWD—
0.00TWD—
0.00TWD—
0.00TWD—
0.00TWD—
0.00TWD—
0.00TWD—
0.00TWD—

Is the MegaPro Biomedical Co Dividend Safe?

MegaPro Biomedical Co has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding MegaPro Biomedical Co's Dividend Distributions

MegaPro Biomedical Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining MegaPro Biomedical Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

MegaPro Biomedical Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in MegaPro Biomedical Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

MegaPro Biomedical Co Stock analysis

What does MegaPro Biomedical Co do? MegaPro Biomedical Co Ltd is a biotechnology company based in Zhubei, Taiwan, operating within the health care sector. The company has a workforce of 20 employees and completed its initial public offering (IPO) on October 19, 2021. Its primary focus is the development of drug ingredients utilizing nanoparticle and nanocell technology platforms. The company's product portfolio includes several compounds designated as MPB-1514, MPB-1523, MPB-1734, and MPB-2043. MPB-1514 is designed for intravenous treatment of anemia associated with chronic kidney disease. MPB-1523 is intended for intravenous diagnosis of hepatocellular carcinoma. MPB-1734 targets solid tumors through intravenous administration. MPB-2043 is used for intravenous diagnosis of metastases in peripheral lymph nodes near cancerous sites. The company maintains a website at https://www.megaprobio.com/ for further information. MegaPro Biomedical Co Ltd operates under the ticker symbol 6827.TWO and is registered with ISIN TW0006827009. It is headquartered in Zhubei, Hsinchu, Taiwan, and is engaged in the development of advanced biotechnological solutions for medical applications. MegaPro Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MegaPro Biomedical Co stock

MegaPro Biomedical Co paid dividends every year for the past 0 years.

MegaPro Biomedical Co is assigned to the 'Health' sector.

The dividends of MegaPro Biomedical Co are distributed in TWD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — MegaPro Biomedical Co